for a family member or friend; however, such donations carry a higher risk for TTIs (6). Since 2004, PEPFAR support has helped establish national blood policies, improved blood donor screening, increased recruitment and reliance on VNRDs for national supplies, and strengthened laboratory infrastructure, accreditation, information systems, and continuous quality improvement programs (4) .
During 2014-2016, NBTSs in the 14 PEPFAR-supported sub-Saharan African countries used a standardized data collection tool to report the total number of blood units collected; the percentage of donated units that screened positive for HIV and other TTIs; the percentage of screen-positive donors who were notified of their result; and the status of financial support transition from PEPFAR to MOHs. MOH funding to support blood safety activities at the local NBTS was self-reported to the PEPFAR and CDC-supported WHO Global Database on Blood Safety. The numbers of whole blood units collected per 1,000 population per year were calculated using national census estimates or United Nations population projections.** During 2004-2016, overall total annual blood collections in PEPFAR-supported countries increased 60%, from 1,469,561 units in 2004 to 2,352,905 units in 2016, although collection rates remain below WHO recommendations (1) in all countries except South Africa and Swaziland (Table 1) . From 2014 to 2016, the number of units collected per 1,000 population decreased in five countries (Kenya, Lesotho, Nigeria, Swaziland, and Zambia); however, during this period, eight countries reported collecting 100% of their national blood supply from VNRDs. The largest increase in VNRD donations (40%) occurred in Ethiopia (from 70% in 2014 to 98% in 2016); however, declines in VNRD donations in Lesotho (18%, from 96% to 79%) and Tanzania (11%, from 89% to 79%) also occurred.
In all 14 countries, most blood donors were men (65% in (Figure) . During this period, the total number of deferrals remained steady (>250,000 units); however, deferrals attributable to high-risk behavior declined from 2014 to 2015.
From 2014 to 2016, the prevalence of HBV, HCV, and syphilis reactivity in donated blood units decreased in six countries; decreases ranged from 0.1 percentage point (Tanzania) to 1.3 percentage points (Mozambique) ( Table 2 ). The prevalence of TTIs in donated units increased in seven countries (Côte d'Ivoire, Ghana, Lesotho, Nigeria, Rwanda, South Africa, Swaziland, and Uganda) ( Table 2 ). In 2016, the percentage of donated blood units that screened positive for all TTIs ranged from 0.7 (South Africa) to 14.6 (Nigeria).
As support for local blood safety programs transitioned to MOHs from PEPFAR, MOHs in Ethiopia, Swaziland, and Tanzania completely absorbed the cost of collecting and testing blood in 2016. Nine of 12 countries with available data report ≥50% of MOH support to the NBTS (Supplementary Table, https://stacks.cdc.gov/view/cdc/61188).
Discussion
Sub-Saharan African countries have improved access to safe and adequate blood supplies, but continued commitment and funding are required to maintain gains and achieve WHO targets. Although the number of blood units collected has increased since 2004, whole blood collections remain insufficient to meet national demand: 12 of 14 evaluated countries do not meet the WHO-recommended target (1). This shortfall especially affects women with pregnancy-related complications, trauma victims, and children with severe life-threatening malaria-related anemia (7) .
Although most of the 14 PEPFAR-supported countries reported decreases in the percentage of collected blood units that screened positive for HIV since 2004, percentages remain significantly higher than the 0.003% reported by high-income countries (1). Seven countries have HIV screen-positive rates that exceed the WHO recommended target of <1.0%. Although HIV prevalence rates among blood donors have decreased, prevalences of other TTIs such as HBV, HCV, and syphilis increased in seven countries. To reduce the risk for TTIs in sub-Saharan Africa when PEPFAR support ends, MOHs can participate in cross-sector collaborations to implement blood bank quality and safety accreditation standards through the African Society for Blood Transfusion (AfSBT) † † or other international accrediting bodies and implement PEPFARsupported blood safety information systems. Recent data indicate that 50% of PEPFAR-supported countries still do not have a computerized information system for blood donor tracking and TTI testing. Since 2016, blood safety information systems have been implemented in three countries, with another two planned by 2019. To date, only four NBTSs in sub-Saharan Africa (Namibia [accredited in 2012], South Africa, Rwanda, and Tanzania) have achieved accreditation by an external body. Seven countries are currently in various stages of the accreditation process through AfSBT. Global CDC blood safety targets are that 50% of NBTS sites reach at least the first of three accreditation steps under AfSBT during the next 2-3 years. As countries move toward the United Nations 95-95-95 targets (95% of HIV infection diagnosed, 95% of infected persons receiving antiretroviral therapy [ART] , and 95% of those on ART achieving viral suppression) for achieving epidemic control, increasing outreach to priority populations for testing and preventive services become increasingly important (8) . Currently, no systems exist within these NBTSs to link persons determined to be ineligible for donation through behavioral risk screening to HIV testing and preventive services.
TABLE 2. Population prevalence of human immunodeficiency virus (HIV) infection among persons aged 15-49 years in the general population, percentage of collected blood units reactive for HIV, and percentage of collected blood units reactive for three transfusion-transmissible infections (TTIs) (hepatitis B virus [HBV], hepatitis C virus [HCV], and syphilis), by country -14 U.S. President's Emergency Plan for AIDS
During 2014-2016, four NBTSs transitioned from PEPFAR to full MOH funding. An additional five countries received ≥50% of their funding from MOHs; two countries reported a decrease in MOH funding. As PEPFAR transitions occur, countries should consider prioritization of funding to their NBTS to sustain the gains achieved (9) .
The findings of this report are subject to at least four limitations. First, blood unit collections described in this report only Sustained investments by ministries of health in continuous quality improvement, national blood transfusion services accreditation, linkage of HIV-positive and donors at risk to testing, care, and treatment, and blood safety information systems remain important components to ensure the viability of blood safety programs.
represent units collected by the NBTS, and do not account for units collected in the private sector or by nonnational blood transfusion services. Second, variations in testing capacity and assays used for laboratory screening (most NBTSs lack HBV and HCV confirmatory testing) might result in over-or underestimation of TTI prevalence rates among blood donors. Third, lack of information systems to link donors who screen HIV-positive to treatment services might result in inaccurate estimations of the number of donors who are notified about their status. Finally, self-reported data from countries might result in inaccurate estimations.
A decade of PEPFAR support to NBTSs in 14 countries has led to increases in blood collections, fewer donors screening HIV-positive, and transition of support from PEPFAR to MOHs. However, gaps in linking deferred donors at high risk to HIV testing and prevention services, and in notifying HIVpositive donors of their status and linking them to confirmatory testing, care, and treatment underscore the need for enhanced focus on epidemic control, as well as innovative strategies to address donors who test positive for other TTIs. Ending reliance on unsafe blood donors requires continued investment in laboratory quality improvement, including increased engagement in external proficiency testing and increased use of highly sensitive assays at the NBTS and non-NBTS testing sites. Continued improvement of blood safety programs in subSaharan Africa will require sustained investments in continuous quality improvement, NBTS accreditation under AfSBT, linkage of deferred donors who report high risk behaviors and those who screen HIV-positive to HIV testing services and treatment, and stronger blood safety information systems. Strengthening health systems and developing local policy and sustainable financial resources are all important components to consider to ensure the future viability of blood safety programs.
